{"title":"Carbon Nanotubes Inhibit the Pepsin Activity at High Ionic Strength","authors":"K. M. Jasem, H. Al-Hakeim, Jawad Kadhem Al-Shams","doi":"10.2174/1573408016999200603170618","DOIUrl":null,"url":null,"abstract":"\n\nGastroesophageal reflux disease (GERD) is a common chronic gastrointestinal\ndisorder in adults that occurs as the stomach contents reflux and come up into the esophagus\ndue to a dysfunction in the lower oesophageal sphincter. One approach commonly used to treat\nGERD is inhibition of the activity of pepsin enzyme. Carbon nanotubes (CNTs) are nanoparticles of\ncarbon atoms that possess numerous interesting physical and chemical properties. CTNs functionalization\nexpands the range of their properties to make them soluble in biological fluids and to confer\nthe property of carrying drug or biological macromolecules which increase the scope of their applications\nin biomedical science.\n\n\n\nThis study aims to utilize CNTs as a pepsin inhibitor and as a new medication for the\ntreatment of GERD.\n\n\n\nThe pepsin activity before and after the addition of an exact amount of the CNTs to the reaction\nmixture was measured colorimetrically.\n\n\n\nThe results showed that both Vmax and Km changed after the addition of CNTs to the pepsin\nsolution indicating a mixed inhibition of pepsin activity. This finding pointed to the ability of\nCNTs to bind with the pepsin molecule and pepsin-protein complex, therefore inhibiting the enzyme\nactivity.\n\n\n\nThe findings also demonstrated a complete inhibition of pepsin activity by CNTs when\nincreasing the ionic strength of the reaction mixture. It can be inferred that using CNTs at a high concentration\nof NaCl at 37°C is the optimal condition for pepsin inhibition.\n","PeriodicalId":35405,"journal":{"name":"Current Enzyme Inhibition","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Enzyme Inhibition","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1573408016999200603170618","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 1
Abstract
Gastroesophageal reflux disease (GERD) is a common chronic gastrointestinal
disorder in adults that occurs as the stomach contents reflux and come up into the esophagus
due to a dysfunction in the lower oesophageal sphincter. One approach commonly used to treat
GERD is inhibition of the activity of pepsin enzyme. Carbon nanotubes (CNTs) are nanoparticles of
carbon atoms that possess numerous interesting physical and chemical properties. CTNs functionalization
expands the range of their properties to make them soluble in biological fluids and to confer
the property of carrying drug or biological macromolecules which increase the scope of their applications
in biomedical science.
This study aims to utilize CNTs as a pepsin inhibitor and as a new medication for the
treatment of GERD.
The pepsin activity before and after the addition of an exact amount of the CNTs to the reaction
mixture was measured colorimetrically.
The results showed that both Vmax and Km changed after the addition of CNTs to the pepsin
solution indicating a mixed inhibition of pepsin activity. This finding pointed to the ability of
CNTs to bind with the pepsin molecule and pepsin-protein complex, therefore inhibiting the enzyme
activity.
The findings also demonstrated a complete inhibition of pepsin activity by CNTs when
increasing the ionic strength of the reaction mixture. It can be inferred that using CNTs at a high concentration
of NaCl at 37°C is the optimal condition for pepsin inhibition.
期刊介绍:
Current Enzyme Inhibition aims to publish all the latest and outstanding developments in enzyme inhibition studies with regards to the mechanisms of inhibitory processes of enzymes, recognition of active sites, and the discovery of agonists and antagonists, leading to the design and development of new drugs of significant therapeutic value. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of enzymes that can be exploited for drug development. Current Enzyme Inhibition is an essential journal for every pharmaceutical and medicinal chemist who wishes to have up-to-date knowledge about each and every development in the study of enzyme inhibition.